← Leaderboards
Kang Zhang
Cleveland Clinic Foundation
$12,829,337
Attributed
$19,597,231
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$19,597,231 · 10
VA$0 · 1
By mechanism
R01$19,295,397 · 9
K23$301,834 · 1
I01$0 · 1
Top collaborators
- Sheng Ding5 shared
- Thomas A Reh5 shared
- George L Sen4 shared
- Adah Almutairi3 shared
- Bing Ren3 shared
- Sheng Zhong3 shared
- Kun-Liang Guan2 shared
- Srinivas R Sadda2 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Alan D Marmorstein$7,661,857
- Joe Gilbert Hollyfield$7,576,094
- Bela Anand-Apte$12,006,070
- Lihua Y Marmorstein$4,133,800
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaMolecularGenesMacular DegenerationRetinalPlayBlindnessCellsAge Related Macular DegenerationMutationGeneticPathogenesisLeadHistologyPathway InteractionsProteinsIn VivoOphthalmoscopyImmunohistochemistryPathologyIn VitroKnock-OutElderlyChoroidal Neovascularization
Grant awards (52)
Molecular Mechanism and Therapy for Ocular Melanoma$488,005
R01 · FY2018 · CA · contact PI
Limbal Stem Cell Fate and Corneal Specific Enhancers$474,221
R01 · FY2018 · EY · contact PI
Non-coding Variants Predisposing to Age-related Macular Degeneration$749,531
R01 · FY2017 · HG
Molecular Mechanism and Therapy for Ocular Melanoma$488,005
R01 · FY2017 · CA · contact PI
Limbal Stem Cell Fate and Corneal Specific Enhancers$474,052
R01 · FY2017 · EY · contact PI
HTRA1 and Age-Related Macular Degeneration$0
I01 · FY2017 · VA · contact PI
Non-coding Variants Predisposing to Age-related Macular Degeneration$753,450
R01 · FY2016 · HG
Limbal Stem Cell Fate and Corneal Specific Enhancers$473,889
R01 · FY2016 · EY · contact PI
Biomaterial enhancement of stem cell transplant efficacy for macular degeneration$374,691
R01 · FY2016 · EY
HTRA1 and Age-Related Macular Degeneration$0
I01 · FY2016 · VA · contact PI
Non-coding Variants Predisposing to Age-related Macular Degeneration$786,773
R01 · FY2015 · HG
Limbal Stem Cell Fate and Corneal Specific Enhancers$504,827
R01 · FY2015 · EY · contact PI
Biomaterial enhancement of stem cell transplant efficacy for macular degeneration$368,541
R01 · FY2015 · EY
HTRA1 and Age-Related Macular Degeneration$0
I01 · FY2015 · VA · contact PI
Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli$831,267
R01 · FY2014 · EY · contact PI
Biomaterial enhancement of stem cell transplant efficacy for macular degeneration$377,288
R01 · FY2014 · EY
HTRA1 and Age-Related Macular Degeneration$0
I01 · FY2014 · VA · contact PI
Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli$789,704
R01 · FY2013 · EY · contact PI
Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli$831,267
R01 · FY2012 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$330,383
R01 · FY2012 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$72,540
R01 · FY2012 · EY · contact PI
Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli$831,267
R01 · FY2011 · EY · contact PI
ELOVL4 and Retinal Disease$367,092
R01 · FY2011 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$330,383
R01 · FY2011 · EY · contact PI
Regeneration of Retinal Neurons by Chemically Induced Reprogramming of Muller Gli$954,447
R01 · FY2010 · EY · contact PI
Genetic Susceptibility for Development of Proliferative Diabetic Retinopathy$396,581
R01 · FY2010 · EY
ELOVL4 and Retinal Disease$382,388
R01 · FY2010 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$344,149
R01 · FY2010 · EY · contact PI
Genetic Susceptibility for Development of Proliferative Diabetic Retinopathy$412,081
R01 · FY2009 · EY
ELOVL4 and Retinal Disease$386,250
R01 · FY2009 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$347,625
R01 · FY2009 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$99,445
R01 · FY2009 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$80,000
R01 · FY2009 · EY · contact PI
Genetics and Functional Studies of Age-Related Macular Degeneration$347,625
R01 · FY2008 · EY · contact PI
ELOVL4 and Retinal Disease$223,275
R01 · FY2008 · EY · contact PI
ELOVL4 and Retinal Disease$143,000
R01 · FY2008 · EY · contact PI
GENETICS OF MACULAR DEGENERATION$561,849
R01 · FY2007 · EY · contact PI
ELOVL4 and Retinal Disease$373,750
R01 · FY2007 · EY · contact PI
GENETICS OF MACULAR DEGENERATION$187,473
R01 · FY2007 · EY · contact PI
ELOVL4 and Retinal Disease$50,000
R01 · FY2007 · EY · contact PI
GENETICS OF MACULAR DEGENERATION$9,600
R01 · FY2007 · EY · contact PI
GENETICS OF MACULAR DEGENERATION$568,560
R01 · FY2006 · EY · contact PI
GENETICS OF MACULAR DEGENERATION$373,750
R01 · FY2005 · EY
ELOVL4 and Retinal Disease$366,996
R01 · FY2005 · EY
GENETICS OF MACULAR DEGENERATION$139,663
R01 · FY2005 · EY
GENETICS OF MACULAR DEGENERATION$373,750
R01 · FY2004 · EY
ELOVL4 and Retinal Disease$366,996
R01 · FY2004 · EY
GENETICS OF MACULAR DEGENERATION$373,750
R01 · FY2003 · EY
ELOVL4 and Retinal Disease$366,995
R01 · FY2003 · EY
ELOVL4 and Retinal Disease$368,223
R01 · FY2002 · EY
CLONING OF A GENE FOR DOMINANT STARGARDT'S DISEASE$152,749
K23 · FY2001 · EY
CLONING OF A GENE FOR DOMINANT STARGARDT'S DISEASE$149,085
K23 · FY2000 · EY